Nasdaq Evgn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq evgn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Evgn Today - Breaking & Trending Today

Evogene (NASDAQ:EVGN) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a report released on Wednesday. The firm issued a sell rating on the biotechnology company’s stock. Evogene Trading Down 5.0 % NASDAQ EVGN opened at $0.63 on Wednesday. The business’s fifty day moving average is $0.79 and its 200 day moving average is […] ....

Evogene Ltd , Human Health , Silverarc Capital Management , Securities Exchange Commission , Free Report , Trading Down , Get Free Report , Capital Management , Computational Predictive Biology , Evogene Daily , Nasdaq Evgn , Initiated Coverage , Stocknews Com ,

Silverarc Capital Management LLC Has $1.82 Million Holdings in Evogene Ltd. (NASDAQ:EVGN)

Silverarc Capital Management LLC raised its holdings in Evogene Ltd. (NASDAQ:EVGN – Free Report) by 3,000.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,100,000 shares of the biotechnology company’s stock after purchasing an additional 3,000,000 shares during the quarter. Silverarc Capital […] ....

United States , Renaissance Technologies , Evogene Ltd , Silverarc Capital Management , America Corp , Vident Investment Advisory , Exchange Commission , Virtu Financial , Human Health , Free Report , Capital Management , Investment Advisory , Get Free Report , Computational Predictive Biology , Evogene Daily , Nasdaq Evgn , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Evogene Ltd. (NASDAQ:EVGN) Sees Large Decline in Short Interest

Evogene Ltd. (NASDAQ:EVGN – Get Free Report) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 187,200 shares, a decrease of 35.0% from the November 30th total of 287,800 shares. Based on an average daily volume of 144,100 shares, the days-to-cover ratio is presently 1.3 days. […] ....

United States , Vident Investment Advisory , Silverarc Capital Management , Human Health , America Corp , Renaissance Technologies , Walleye Capital , Alliance Global Partners , Evogene Ltd , Get Free Report , Global Partners , Stock Down , Capital Management , Investment Advisory , Computational Predictive Biology , Evogene Daily , Nasdaq Evgn ,

Alliance Global Partners Begins Coverage on Evogene (NASDAQ:EVGN)

Alliance Global Partners assumed coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a research report released on Monday, Marketbeat reports. The firm issued a buy rating and a $1.85 price objective on the biotechnology company’s stock. A number of other analysts have also recently issued reports on EVGN. StockNews.com began coverage on Evogene […] ....

Roth Mkm , Evogene Ltd , Vident Investment Advisory , Alliance Global Partners , Virtu Financial , Silverarc Capital Management , Human Health , Renaissance Technologies , Free Report , Street Capital , Get Free Report , Capital Management , Investment Advisory , Computational Predictive Biology , Evogene Daily , Nasdaq Evgn , Initiated Coverage ,

Lake Street Capital Boosts Evogene (NASDAQ:EVGN) Price Target to $3.00

Evogene (NASDAQ:EVGN – Free Report) had its target price lifted by Lake Street Capital from $2.00 to $3.00 in a research note released on Friday morning, MarketBeat.com reports. They currently have a buy rating on the biotechnology company’s stock. EVGN has been the topic of several other research reports. StockNews.com initiated coverage on Evogene in […] ....

Roth Mkm , Silverarc Capital Management , Evogene Company Profile , Vident Investment Advisory , Evogene Ltd , Human Health , Renaissance Technologies , Virtu Financial , Free Report , Lake Street Capital , Get Free Report , Investment Advisory , Capital Management , Computational Predictive Biology , Evogene Daily , Nasdaq Evgn , Boost Price Target ,